ViroShield IgY

The venture aims to develop an immunotherapy for viral infections affecting the respiratory system, derived from antibodies found in egg yolk. The approach utilizes a proven technology that has demonstrated effectiveness in laboratory and animal studies, with the goal of combating infections and mitigating future pandemics.